Anzeige
Mehr »
Samstag, 29.08.2026 - Börsentäglich über 12.000 News
Vom Forschungstrend zum Milliardenmarkt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41NVB | ISIN: US5240382052 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
AIMWELL PARTNERS INC Chart 1 Jahr
5-Tage-Chart
AIMWELL PARTNERS INC 5-Tage-Chart

Aktuelle News zur AIMWELL PARTNERS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAimwell Partners: The IP Was Only Half the Acquisition: Aimwell Bio Closes the Trustr IP Purchase and Begins Bringing Aboard the People Who Built It431Definitive agreement executed with inventor Dr. Christopher A. Jones; contributors and strategic advisors from the platform's development history to be announced individually as their agreements are...
► Artikel lesen
17.08.Aimwell Partners: AimwellBio Secures Patented Behavioral AI Portfolio Backed by Oxford Science and Sanofi Pilot; Inventor Dr. Chris A. Jones Joins Board of Advisors397Executed IP assignment brings a decade of technology, published research, and pharma-tested behavioral engagement capabilities into AimwellBio as the Company expands its scientific and medical advisory...
► Artikel lesen
13.08.Aimwell Partners: AimwellBio Publishes Investor Briefing on Acquired Trustr Intellectual Property Portfolio Valued at $10m Reinforcing Commitment to Transparency240Behavioral engagement technology carries documented institutional lineage spanning Oxford, the University of Vermont, Cornell, AMCP, and a Sanofi pilot program, as inventor Dr. Chris A. Jones joins...
► Artikel lesen
AIMWELL PARTNERS Aktie jetzt für 0€ handeln
06.08.Aimwell Partners Announces Agreement in Principle to Acquire Intellectual Property Valued at Approximately $10 Million501MIAMI, FL / ACCESS Newswire / August 6, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that it has reached an agreement in principle to acquire a portfolio...
► Artikel lesen
27.07.Aimwell Partners: The World's Most Valuable Healthcare Database May Already Exist, The Problem Is Nobody Knows Who to Trust Inside It388AimwellBio (AIMN) is building the Federated Health Intelligence Network - and preparing to introduce the physicians, scientists and healthcare experts whose knowledge deserves greater visibility. MIAMI...
► Artikel lesen
22.07.Aimwell Partners Inc. Opens No-Cost Observer Access and Publishes The Standard Behind Its Verified Intelligence Platform354Credentialed biopharma professionals can now access AimwellBio's Observer tier at no cost, while the company publishes the Adversarial Validation Standard, v1-the methodology behind every verified intelligence...
► Artikel lesen
20.07.The Doctors Who Actually Know Things Have Spent Twenty Years Being Cited and Never Credited. Aimwell Partners Inc. Is Building the Network That Puts Their Names on the Record329Aimwell Partners Inc. (OTCID:AIMN) publishes the contributor page of Christopher A. Jones, PhD, FRSM, as its Federated Health Intelligence Network expands through credentialed professional referral....
► Artikel lesen
15.07.Aimwell Partners Inc. Confirms Advanced Discussions With Curated Life Sciences Capital Network419MIAMI, FL / ACCESS Newswire / July 15, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today confirmed it is engaged in advanced discussions with an exclusive, referral-based...
► Artikel lesen
13.07.Aimwell Partners enters final talks for $10M healthcare IP acquisition deal1
13.07.Aimwell Partners Inc. Enters Final Negotiations to Acquire Healthcare Intellectual Property Independently Valued at $10 Million361MIAMI, FL / ACCESS Newswire / July 13, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today announced that it has entered final-stage negotiations to acquire a portfolio of healthcare-related intellectual...
► Artikel lesen
08.07.The Professionals Arrived First - Now Their Institutions are Following: Aimwell Partners Inc. Confirms Enterprise Interest Driven by Its Credentialed Observer Network311MIAMI, FL / ACCESS Newswire / July 8, 2026 / Aimwell Partners Inc. (OTCID:AIMN) - Technology adoption rarely begins with procurement. It begins with the professionals doing the work.Analysts, regulatory...
► Artikel lesen
06.07.Every AI Intelligence Platform Asks the Market to Trust Its Numbers. Aimwell Partners Inc. Just Opened the Data289419 regulatory, clinical, and research signals are now publicly available at aimwellbio.com/signals-no login, no sales call, and no requirement to take the company's word for anything. MIAMI, FL / ACCESS...
► Artikel lesen
01.07.Aimwell Partners Inc. Publishes the Adversarial Validation Standard, v1, an Open Methodology Framework for Verifying AI-Generated Biopharma Intelligence378MIAMI, FL / ACCESS Newswire / July 1, 2026 / Aimwell Partners Inc. (OTCID:AIMN) ("Aimwell" or the "Company"), the parent company of AimwellBio, today announced the publication of the Adversarial Validation...
► Artikel lesen
29.06.Aimwell Partners: AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn Signup926Aimwell Partners Inc. (OTC PINK:AIMN) is actively onboarding doctors, scientists, researchers, and capital professionals into AimwellBio Observer, a credentialed intelligence network where members read...
► Artikel lesen
22.06.Aimwell Partners: AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor520With over one billion Americans' health records now breached and the largest incidents shifting to mission-critical third parties, Aimwell Partners Inc. is exploring verified infrastructure that adds...
► Artikel lesen
17.06.Aimwell Partners: AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare Intelligence469DENVER, CO / ACCESS Newswire / June 17, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today announced an expansion of technical capabilities supporting AimwellBio, the Company's healthcare intelligence...
► Artikel lesen
15.06.Aimwell Partners: AimwellBio Opens Verified Observer Network to Healthcare, Research, and Capital Professionals at No Cost309Aimwell Partners Inc. (OTCID:AIMN) expands Observer access, a credentialed professional intelligence network for biopharma, inviting doctors, scientists, regulatory professionals, and capital allocators...
► Artikel lesen
10.06.Aimwell Partners: The Question No Telehealth Underwriter Wants Asked: When was Your Platform Last Breached, and Would You Even Know?180Aimwell Partners Inc. (OTC:AIMN) advances a verified collaboration mesh for healthcare intelligence, built on identity, encryption, and chain-of-custody integrity rather than the legacy internet infrastructure...
► Artikel lesen
08.06.Aimwell Partners: As Healthcare's Software Leaders Race to Add AI, AimwellBio.com Moves to Build the Layer That Verifies It327Aimwell Partners Inc. explores verified biomedical intelligence infrastructure, positioning verification as the next essential layer in a proven, multi-billion-dollar medical software ecosystem DENVER...
► Artikel lesen
01.06.Aimwell Partners: AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In340A new professional intelligence network is forming around the people who shape clinical, research, regulatory, and capital decisions. Observer access is free. The credentialing is not. And the first...
► Artikel lesen
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1